PT-141 is unique in that it works centrally — on melanocortin receptors in the hypothalamus — addressing the arousal deficit that vascular compounds cannot touch, and it has completed Phase III trials for hypoactive sexual desire disorder. Kisspeptin-10 enhances the hormonal milieu by stimulating endogenous testosterone and sex hormone production at the HPG axis level, while BPC-157 supports vascular and tissue health in sexual organs. This combination addresses the neurological, hormonal, and vascular components of sexual function in a single protocol — effective for both men and women.
On-Demand Arousal Protocol (PT-141):
Notes: PT-141 commonly causes mild, transient nausea and facial flushing — these subside within 1–2 hours and are dose-dependent. Taking with a small meal reduces nausea. Do not combine PT-141 with antihypertensives without medical supervision.
Use the Peptide Oracle calculator to get exact BAC water ratios and draw amounts for every peptide in this protocol.
Open Dosage Calculator